(Bristol, VA) – Innovative Technologies added three new trademarks to its pharmaceutical pipeline on Monday.

Cacinin® is designed to treat metastatic cancer with fewer side effects than traditional chemotherapy because it specifically targets tumor cells.

Cardiosafe® is designed to treat reperfusion damage following a heart attack.

Polyphetamine® is a new product for the treatment of ADHD and narcolepsy.

“This is one of the most exciting times in our drug development program—when we see that these products are getting close to clinical trials and treatment of these diseases,” says Dr. Keith R. Latham, President and Chief Scientist of Innovative Technologies.

Innovative Technologies, an expanding company in southwest Virginia, has seven divisions, including Innovative Technologies (ITL), Inovar Pharmaceuticals (IPL), Inovar Chemicals (IVC), Global Distribution and Cold Storage (GDCS), Highlands Flying Service (HFS), ITL Printing (ITP) and Plastic Molding Corporation (PMC). For more information, please visit www.itlpharma.com.

For media inquiries, contact Eric Latham at (276) 494-1656.